These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 22424185

  • 1. Synthesis, characterization, and in vitro studies of bis[1,3-diethyl-4,5-diarylimidazol-2-ylidene]gold(I/III) complexes.
    Liu W, Bensdorf K, Proetto M, Hagenbach A, Abram U, Gust R.
    J Med Chem; 2012 Apr 26; 55(8):3713-24. PubMed ID: 22424185
    [Abstract] [Full Text] [Related]

  • 2. NHC gold halide complexes derived from 4,5-diarylimidazoles: synthesis, structural analysis, and pharmacological investigations as potential antitumor agents.
    Liu W, Bensdorf K, Proetto M, Abram U, Hagenbach A, Gust R.
    J Med Chem; 2011 Dec 22; 54(24):8605-15. PubMed ID: 22091836
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis, antitumor, and antibacterial activity of bis[4,5-diarylimidazol-2-ylidene]methane derivatives.
    Liu W, Chen X, Gust R.
    Arch Pharm (Weinheim); 2012 Jul 22; 345(7):557-64. PubMed ID: 22467535
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.
    Wiglenda T, Ott I, Kircher B, Schumacher P, Schuster D, Langer T, Gust R.
    J Med Chem; 2005 Oct 06; 48(20):6516-21. PubMed ID: 16190777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synthesis and characterization of azolate gold(I) phosphane complexes as thioredoxin reductase inhibiting antitumor agents.
    Galassi R, Burini A, Ricci S, Pellei M, Rigobello MP, Citta A, Dolmella A, Gandin V, Marzano C.
    Dalton Trans; 2012 May 07; 41(17):5307-18. PubMed ID: 22391922
    [Abstract] [Full Text] [Related]

  • 13. Anticancer cyclometalated [Au(III)m(C(wedge)N(wedge)C)mL]n+ compounds: Synthesis and cytotoxic properties.
    Li CK, Sun RW, Kui SC, Zhu N, Che CM.
    Chemistry; 2006 Jul 05; 12(20):5253-66. PubMed ID: 16642532
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A, Diawara MC, Scopelliti R, Zakeeruddin SM, Grätzel M, Dyson PJ.
    Dalton Trans; 2010 Mar 07; 39(9):2239-45. PubMed ID: 20162197
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A gold(I) phosphine complex containing a naphthalimide ligand functions as a TrxR inhibiting antiproliferative agent and angiogenesis inhibitor.
    Ott I, Qian X, Xu Y, Vlecken DH, Marques IJ, Kubutat D, Will J, Sheldrick WS, Jesse P, Prokop A, Bagowski CP.
    J Med Chem; 2009 Feb 12; 52(3):763-70. PubMed ID: 19123857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.